Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Naruse, Keiko ^a   Sato, Jun ^b   Funakubo, Megumi ^b   Hata, Masaki ^a   Nakamura, Nobuhisa ^a   Kobayashi, Yasuko ^a   Kamiya, Hideki ^c   Shibata, Taiga ^d   Kondo, Masaki ^d   Himeno, Tatsuhito ^d   Matsubara, Tatsuaki ^a   Oiso, Yutaka ^d   Nakamura, Jiro ^c  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; MESSENGER RNA; NEUROTROPHIN 3; SODIUM CHLORIDE; STREPTOZOCIN; NERVE GROWTH FACTOR;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOTRANSPLANTATION; BLOOD FLOW; BONE MARROW CELL; CELL DENSITY; CELL ISOLATION; CELL TRANSPLANTATION; COLD ALLODYNIA; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE MODEL; GENE EXPRESSION; HINDLIMB; HISTOLOGY; HYPERALGESIA; INJECTION SITE; MALE; MICROVASCULATURE; MONONUCLEAR CELL; MOTOR NERVE CONDUCTION; MOUSE; MUSCLE EXCITATION; NERVE CELL; NERVE FUNCTION; NONHUMAN; SCIATIC NERVE; SENSORY NERVE CONDUCTION; ANIMAL; BLOOD FLOW VELOCITY; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CAPILLARY; COLD; EXPERIMENTAL DIABETES MELLITUS; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; NERVE FIBER; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; TRANSPLANTATION; VASCULARIZATION;

RATTUS;

ANIMALS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CAPILLARIES; COLD TEMPERATURE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GENE EXPRESSION; HYPERALGESIA; LEUKOCYTES, MONONUCLEAR; MALE; MUSCLE, SKELETAL; NERVE FIBERS; NERVE GROWTH FACTORS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCIATIC NERVE;

EID: 81355136050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027458     Document Type: Article

References (51)

1. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM, (2004) Diabetic somatic neuropathies. Diabetes Care 27: 1458-1486.
2. Tesfaye S, (2011) Recent advances in the management of diabetic distal symmetrical polyneuropathy. J Diabetes Invest 2: 33-42.
3. Obrosova IG, (2009) Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics 6: 638-647.
4. Kamiya H, Zhang W, Sima AA, (2004) C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes. Ann Neurol 56: 827-835.
5. Latham JR, Pathirathna S, Jagodic MM, Joo Choe W, Levin ME, et al. (2009) Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58: 2656-2665.
6. Li F, Abatan OI, Kim H, Burnett D, Larkin D, et al. (2006) Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats. Neurobiol Dis 22: 669-676.
7. Cameron NE, Jack AM, Cotter MA, (2001) Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med 31: 125-135.
8. Ilnytska O, Lyzogubov VV, Stevens MJ, Drel VR, Mashtalir N, et al. (2006) Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes 55: 1686-1694.
9. Calcutt NA, Freshwater JD, Mizisin AP, (2004) Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47: 718-724.
10. Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM, (2003) Mechanical hyperalgesia in rat models of systemic and local hyperglycemia. Brain Res 960: 174-183.
11. Ziegler D, (2008) Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31 (Suppl 2): S255-261.
12. Yagihashi S, Mizukami H, Sugimoto K, (2011) Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Invest 2: 18-32.
13. Eaton SE, Harris ND, Ibrahim S, Patel KA, Selmi F, et al. (2003) Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy. Diabetologia 46: 934-939.
14. Quattrini C, Harris ND, Malik RA, Tesfaye S, (2007) Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care 30: 655-659.
15. Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR, (2008) Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells. J Vasc Surg 48: 53S-60S.
16. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435.
17. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, et al. (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052.
18. Van Damme A, Vanden Driessche T, Collen D, Chuah MK, (2002) Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2: 195-209.
19. Naruse K, Hamada Y, Nakashima E, Kato K, Mizubayashi R, et al. (2005) Therapeutic neovascularization using cord blood-derived endothelial progenitor cells for diabetic neuropathy. Diabetes 54: 1823-1828.
20. Shibata T, Naruse K, Kamiya H, Kozakae M, Kondo M, et al. (2008) Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 57: 3099-3107.
21. Hasegawa T, Kosaki A, Shimizu K, Matsubara H, Mori Y, et al. (2006) Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats. Exp Neurol 199: 274-280.
22. Kim H, Park JS, Choi YJ, Kim MO, Huh YH, et al. (2009) Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy. Stem Cells 27: 1686-1696.
23. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM, (1994) Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59: 369-376.
24. Hotta N, Koh N, Sakakibara F, Nakamura J, Hamada Y, et al. (1996) Effects of beraprost sodium and insulin on the electroretinogram, nerve conduction, and nerve blood flow in rats with streptozotocin-induced diabetes. Diabetes 45: 361-366.
25. Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, et al. (2001) Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 107: 1083-1092.
26. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
27. Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, et al. (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111: 360-367.
28. Bril V, England J, Franklin GM, Backonja M, Cohen J, et al. (2011) Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 76: 1758-1765.
29. Marin P, Andersson B, Krotkiewski M, Bjorntorp P, (1994) Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care 17: 382-386.
30. Schachinger V, Assmus B, Erbs S, Elsasser A, Haberbosch W, et al. (2009) Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial. Eur J Heart Fail 11: 973-979.
31. Tse HF, Siu CW, Zhu SG, Songyan L, Zhang QY, et al. (2007) Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. Eur J Heart Fail 9: 747-753.
32. Yuen KC, Baker NR, Rayman G, Reddy A, Edelsten C, (2002) Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study. Diabetes Care 25: 1699-1703.
33. Rayman G, Baker NR, Krishnan ST, (2003) Glyceryl trinitrate patches as an alternative to isosorbide dinitrate spray in the treatment of chronic painful diabetic neuropathy. Diabetes Care 26: 2697-2698.
34. Anderson KJ, Dam D, Lee S, Cotman CW, (1988) Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature 332: 360-361.
35. Cummings BJ, Yee GJ, Cotman CW, Anderson KJ, Dam D, et al. (1992) bFGF promotes the survival of entorhinal layer II neurons after perforant path axotomy. Brain Res 591: 271-276.
36. Nakae M, Kamiya H, Naruse K, Horio N, Ito Y, et al. (2006) Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55: 1470-1477.
37. Huang EJ, Reichardt LF, (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736.
38. Wilson-Gerwing TD, Stucky CL, McComb GW, Verge VM, (2008) Neurotrophin-3 significantly reduces sodium channel expression linked to neuropathic pain states. Exp Neurol 213: 303-314.
39. Zhuang HX, Snyder CK, Pu SF, Ishii DN, (1996) Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Exp Neurol 140: 198-205.
40. Lachtermacher S, Esporcatte BL, da Silva de Azevedo Fortes F, Rocha NN, Montalvao F, et al. (2011) Functional and Transcriptomic Recovery of Infarcted Mouse Myocardium Treated with Bone Marrow Mononuclear Cells. Stem Cell Rev Available: http://www.springerlink.com/content/ur3n476u51045hx4/. Accessed 2011 Jun 14.
41. Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, et al. (2003) Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 306: 804-814.
42. Kang S, Wu C, Banik RK, Brennan TJ, (2010) Effect of capsaicin treatment on nociceptors in rat glabrous skin one day after plantar incision. Pain 148: 128-140.
43. Kapur D, (2003) Neuropathic pain and diabetes. Diabetes Metab Res Rev 19 (Suppl 1): S9-15.
44. Dyck PJ, Lambert EH, O'Brien PC, (1976) Pain in peripheral neuropathy related to rate and kind of fiber degeneration. Neurology 26: 466-471.
45. Lauria G, Lombardi R, Borgna M, Penza P, Bianchi R, et al. (2005) Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10: 202-208.
46. Suzuki Y, Sato J, Kawanishi M, Mizumura K, (2002) Tissue glucose level modulates the mechanical responses of cutaneous nociceptors in streptozotocin-diabetic rats but not normal rats in vitro. Pain 99: 475-484.
47. Fuchs D, Birklein F, Reeh PW, Sauer SK, (2010) Sensitized peripheral nociception in experimental diabetes of the rat. Pain 151: 496-505.
48. Khan GM, Chen SR, Pan HL, (2002) Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114: 291-299.
49. Jarvis MF, Wessale JL, Zhu CZ, Lynch JJ, Dayton BD, et al. (2000) ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol 388: 29-35.
50. Inkster ME, Cotter MA, Cameron NE, (2007) Treatment with the xanthine oxidase inhibitor, allopurinol, improves nerve and vascular function in diabetic rats. Eur J Pharmacol 561: 63-71.
51. Fuchs D, Birklein F, Reeh PW, Sauer SK, (2010) Sensitized peripheral nociception in experimental diabetes of the rat. Pain 151: 496-505.